PDUFA III Includes Risk Management Fees For “Peri-Approval” Phase
Executive Summary
The FDA/industry PDUFA III agreement includes funding to expand FDA's Office of Drug Safety by 100 full-time equivalent staff positions over five years
You may also be interested in...
FDA Opposes Enzi/Kennedy Drug Safety Bill; Action More Likely Through PDUFA
Pending drug safety legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) may do more harm than good, FDA implied in comments submitted to the Senate Health Committee
FDA Opposes Enzi/Kennedy Drug Safety Bill; Action More Likely Through PDUFA
Pending drug safety legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) may do more harm than good, FDA implied in comments submitted to the Senate Health Committee
Drug Safety User Fees Explored By Sen. Grassley In Questions For Crawford
Senate Finance Committee Chairman Charles Grassley is interested in the idea of funding FDA's drug safety activities with user fees